Extreme alkaline phosphatase elevation associated with tigecycline

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 952-953

  Bonilla, Maria Fernanda ^a   Avery, Robin K ^a   Rehm, Susan J ^a   Neuner, Elizabeth A ^a   Isada, Carlos M ^a   van Duin, David ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adverse events; Drug related; Glycylcyclines

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARBAPENEM; POSACONAZOLE; TIGECYCLINE;

ABDOMINAL ABSCESS; ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BURKHOLDERIA CEPACIA; COHORT ANALYSIS; DEMOGRAPHY; DRUG WITHDRAWAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INFECTIOUS ARTHRITIS; KLEBSIELLA PNEUMONIAE; LETTER; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; OSTEOMYELITIS; PNEUMONIA; POSTOPERATIVE INFECTION; PROSTHESIS INFECTION; RETROSPECTIVE STUDY; SIDE EFFECT; STENOTROPHOMONAS MALTOPHILIA; TREATMENT DURATION; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; ANTI-BACTERIAL AGENTS; DRUG TOXICITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINOCYCLINE; YOUNG ADULT;

EID: 79952784586     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr015     Document Type: Letter

References (7)

1. Schafer JJ, Goff DA. Establishing the role of tigecycline in an era of antimicrobial resistance. Expert Rev Anti Infect Ther 2008; 6: 557-67.
2. Babinchak T, Ellis-Grosse E, Dartois N et al. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 2005; 41 Suppl 5: S354-67.
3. Rose WE, Rybak MJ. Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy 2006; 26: 1099-110.
4. Hung WY, Kogelman L, Volpe G et al. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents 2009; 34: 486-9.
5. Pieringer H, Schmekal B, Biesenbach G et al. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline. Ann Hematol 2010; 89: 1063-4.
6. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
7. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-9.